marketcaparena

MRX

Marex Group Ltd

Company overview

Market capitalization
—
Employees
3,331
Latest publication
2026-09-29
About Marex Group Ltd

Marex Group plc, a financial services platform company, provides liquidity, market access, and infrastructure services to clients in the commodity and financial markets in the United Kingdom, the United States, and internationally. It operates through Clearing, Agency and Execution, Market Making, and Hedging and Investment Solutions segments. The company offers execution and clearing services in metals, agricultural products, energy and fixed income, financial securities, digital assets, and equity futures and options; liquidity, execution, and risk management solutions to financial markets. It also provides liquidity to clients in the OTC energy markets; market data, analytics, and market commentary; energy services, including gas, power, environmental, and crude oil markets; and market-making services across commodities markets, such as metals, agricultural products, and energy markets. In addition, the company offers OTC traded hedging and customized OTC derivatives solutions; and risk management solutions across a spectrum of markets, including agriculture, currency, and interest rate markets for trading houses, producers and consumers, and banks and distributors. Further, it engages in the structured notes business, which allows investors to build structured notes across asset classes, including commodities, equities, foreign exchange, and fixed-income products for private banks, independent asset managers, pension funds, and corporates; and a portfolio of structured Notes, including auto-callable, fixed, stability, and credit-linked notes. Additionally, the company offers technology platforms, including Neon, a trading, risk, and data platform; and Agile, a commodity broking platform. Marex Group plc was incorporated in 2005 and is based in London, the United Kingdom.

Company website

Financial statements

Income Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Total Revenue1,333,400,000USD3,129,700,000USD484,600,000USD500,100,000USD865,700,000USD2,154,800,000USD391,200,000USD740,000,000USD
Cost Of Revenue845,500,000USD611,800,000USD292,000,000USD305,900,000USD544,700,000USD1,158,700,000USD241,700,000USD448,900,000USD
Gross Profit487,900,000USD2,517,900,000USD192,600,000USD194,200,000USD321,000,000USD996,100,000USD391,200,000USD291,100,000USD
Unclassified Operating Expenses970,900,000USD1,457,900,000USD390,000,000USD93,400,000USD81,700,000USD159,800,000USD-79,000,000USD291,100,000USD
Total Operating Expenses970,900,000USD1,457,900,000USD390,000,000USD93,400,000USD81,700,000USD159,800,000USD-79,000,000USD291,100,000USD
Operating Income362,500,000USD1,060,000,000USD94,600,000USD100,800,000USD239,300,000USD437,100,000USD79,000,000USD391,200,000USD
Interest Expense216,400,000USD760,200,000USD——145,400,000USD413,100,000USD—125,000,000USD
Net Interest Income-216,400,000USD———-145,400,000USD——-125,000,000USD
Income Before Tax149,800,000USD308,000,000USD98,800,000USD103,600,000USD98,000,000USD156,800,000USD79,000,000USD139,000,000USD
Tax Provision37,500,000USD25,700,000USD25,600,000USD26,900,000USD25,500,000USD—20,600,000USD20,800,000USD
Net Income112,400,000USD231,500,000USD73,200,000USD76,700,000USD72,500,000USD115,100,000USD58,400,000USD102,900,000USD
Net Income From Continuing Ops112,300,000USD85,500,000USD73,200,000USD76,700,000USD72,500,000USD0USD79,000,000USD59,300,000USD
Reconciled Depreciation11,700,000USD10,000,000USD9,600,000USD8,600,000USD7,900,000USD—6,800,000USD7,700,000USD
Total Other Income Expense Net3,700,000USD-752,000,000USD4,200,000USD2,800,000USD-141,300,000USD-288,300,000USD79,000,000USD-252,200,000USD
Income Tax Expense—76,800,000USD—26,900,000USD25,500,000USD41,700,000USD—36,100,000USD
Ebit—1,071,000,000USD—100,800,000USD243,400,000USD437,100,000USD—391,200,000USD
Ebitda—1,098,500,000USD—109,400,000USD251,300,000USD450,500,000USD79,000,000USD406,600,000USD
Depreciation And Amortization—27,500,000USD—8,600,000USD7,900,000USD13,400,000USD—15,400,000USD
Minority Interest———————-3,300,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Income Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Total Revenue3,629,800,000USD2,894,800,000USD2,352,300,000USD1,175,300,000USD851,700,000USD757,528,000USD549,193,000USD384,466,000USD
Cost Of Revenue917,700,000USD1,607,600,000USD659,400,000USD313,000,000USD609,500,000USD———
Gross Profit2,712,100,000USD1,287,200,000USD1,692,900,000USD862,300,000USD825,300,000USD757,528,000USD549,193,000USD384,466,000USD
Selling General Administrative288,800,000USD247,100,000USD182,100,000USD120,100,000USD82,500,000USD———
Unclassified Operating Expenses1,262,500,000USD203,800,000USD—103,000,000USD62,300,000USD700,190,000USD540,554,000USD339,165,000USD
Total Operating Expenses1,551,300,000USD450,900,000USD798,800,000USD223,100,000USD144,800,000USD700,953,000USD541,193,000USD339,225,000USD
Operating Income1,160,800,000USD836,300,000USD683,500,000USD270,500,000USD68,600,000USD56,575,000USD12,230,000USD45,241,000USD
Interest Expense760,200,000USD538,100,000USD470,200,000USD165,000,000USD26,400,000USD———
Net Interest Income-770,500,000USD-546,800,000USD-475,600,000USD-169,100,000USD-29,700,000USD———
Income Before Tax411,600,000USD295,800,000USD196,500,000USD121,600,000USD69,900,000USD54,984,000USD46,626,000USD13,433,000USD
Income Tax Expense103,700,000USD77,800,000USD55,200,000USD23,400,000USD13,400,000USD11,161,000USD10,234,000USD3,281,000USD
Tax Provision103,700,000USD77,800,000USD55,200,000USD23,400,000USD13,400,000USD———
Net Income308,200,000USD218,000,000USD128,000,000USD91,600,000USD56,500,000USD43,823,000USD36,392,000USD10,152,000USD
Net Income From Continuing Ops307,900,000USD218,000,000USD141,300,000USD98,200,000USD56,500,000USD———
Ebit1,171,800,000USD837,000,000USD683,500,000USD270,500,000USD96,300,000USD54,984,000USD46,626,000USD—
Ebitda1,207,900,000USD865,800,000USD705,400,000USD284,300,000USD106,600,000USD18,564,000USD34,396,000USD—
Depreciation And Amortization36,100,000USD28,800,000USD21,900,000USD13,800,000USD10,300,000USD-36,420,000USD-12,230,000USD—
Reconciled Depreciation36,100,000USD28,800,000USD21,900,000USD13,800,000USD10,300,000USD———
Total Other Income Expense Net-749,200,000USD-540,500,000USD-487,000,000USD-148,900,000USD1,300,000USD-1,591,000USD34,396,000USD-31,808,000USD
Minority Interest-500,000USD-13,300,000USD-13,300,000USD-6,600,000USD0USD———
Selling And Marketing Expenses——616,700,000USD—————
Interest Income——591,800,000USD194,400,000USD23,100,000USD———
Research Development—————763,000USD639,000USD60,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Total Assets36,530,100,000USD34,675,100,000USD32,940,100,000USD31,188,300,000USD24,354,500,000USD24,312,500,000USD19,505,700,000USD17,189,400,000USD
Intangible Assets94,700,000USD335,400,000USD71,400,000USD66,900,000USD54,500,000USD56,500,000USD220,000,000USD53,700,000USD
Total Liab35,183,600,000USD33,411,500,000USD31,756,500,000USD30,077,100,000USD23,308,300,000USD23,335,600,000USD18,545,900,000USD16,307,100,000USD
Total Stockholder Equity1,348,800,000USD1,263,800,000USD1,179,500,000USD1,111,200,000USD1,046,200,000USD976,900,000USD959,800,000USD882,300,000USD
Other Current Liab9,995,400,000USD10,241,600,000USD9,409,600,000USD—7,249,400,000USD9,396,100,000USD652,100,000USD5,381,000,000USD
Capital Stock100,000USD100,000USD100,000USD—100,000USD100,000USD—100,000USD
Retained Earnings1,081,700,000USD982,000,000USD896,700,000USD828,200,000USD775,300,000USD722,400,000USD—611,200,000USD
Good Will237,200,000USD237,400,000USD248,300,000USD215,100,000USD225,000,000USD176,500,000USD—167,400,000USD
Cash3,068,900,000USD6,378,000,000USD3,107,700,000USD6,908,700,000USD2,606,700,000USD2,556,600,000USD5,829,200,000USD1,914,200,000USD
Total Current Assets35,424,500,000USD24,527,600,000USD32,130,600,000USD21,937,500,000USD23,775,300,000USD23,828,500,000USD13,947,600,000USD16,665,200,000USD
Total Current Liabilities32,777,500,000USD7,753,100,000USD29,027,000,000USD16,663,300,000USD21,769,100,000USD21,779,200,000USD11,064,100,000USD15,267,300,000USD
Net Debt7,198,900,000USD3,789,800,000USD5,599,800,000USD1,639,800,000USD4,206,100,000USD3,583,200,000USD-860,500,000USD2,454,900,000USD
Short Long Term Debt7,988,700,000USD7,810,400,000USD6,055,000,000USD3,290,700,000USD5,267,000,000USD4,577,400,000USD2,333,700,000USD1,844,400,000USD
Long Term Debt2,279,100,000USD2,327,300,000USD2,652,500,000USD5,257,800,000USD1,462,700,000USD1,484,900,000USD2,635,000,000USD971,400,000USD
Long Term Investments220,800,000USD111,600,000USD86,000,000USD8,533,500,000USD29,500,000USD77,500,000USD5,111,700,000USD17,500,000USD
Short Term Investments3,822,800,000USD7,078,600,000USD4,243,700,000USD—2,730,300,000USD2,657,000,000USD—2,532,600,000USD
Net Receivables10,684,500,000USD11,071,000,000USD11,042,800,000USD13,557,100,000USD9,747,100,000USD9,549,400,000USD7,109,800,000USD6,130,200,000USD
Inventory300,100,000USD483,700,000USD179,500,000USD—104,100,000USD35,800,000USD—123,000,000USD
Accounts Payable14,765,700,000USD11,781,700,000USD13,528,300,000USD13,372,600,000USD9,204,000,000USD7,741,000,000USD8,078,300,000USD6,523,300,000USD
Property Plant Equipment Net109,100,000USD110,900,000USD88,500,000USD—86,800,000USD80,700,000USD—79,000,000USD
Property Plant Equipment Gross109,100,000USD160,900,000USD88,500,000USD—86,800,000USD126,800,000USD—79,000,000USD
Common Stock Shares Outstanding71,930,870shares76,126,884shares71,699,922shares71,699,922shares78,804,348shares78,221,410shares80,000,000shares72,221,843shares
Non Current Assets Total1,105,600,000USD10,147,500,000USD809,500,000USD9,250,800,000USD579,200,000USD484,000,000USD5,558,100,000USD524,200,000USD
Non Current Liabilities Total2,406,100,000USD25,658,400,000USD2,729,500,000USD13,413,800,000USD1,539,200,000USD1,556,400,000USD7,481,800,000USD1,039,800,000USD
Non Currrent Assets Other353,100,000USD3,781,700,000USD294,700,000USD435,300,000USD153,900,000USD46,100,000USD226,400,000USD185,900,000USD
Net Working Capital2,647,000,000USD2,733,500,000USD3,103,600,000USD5,274,200,000USD2,006,200,000USD2,049,300,000USD-1,857,300,000USD1,397,900,000USD
Unclassified Current Assets17,548,200,000USD-483,700,000USD13,556,900,000USD—————
Unclassified Non Current Assets90,700,000USD5,570,500,000USD20,600,000USD—29,500,000USD46,700,000USD—20,700,000USD
Unclassified Non Current Liabilities127,000,000USD23,331,100,000USD77,000,000USD1,096,500,000USD76,500,000USD71,500,000USD4,740,800,000USD-903,000,000USD
Unclassified Equity267,000,000USD266,200,000USD282,700,000USD167,700,000USD268,600,000USD276,900,000USD959,800,000USD276,900,000USD
Common Stock—100,000USD—100,000USD100,000USD100,000USD—100,000USD
Cash And Short Term Investments—13,456,600,000USD—6,908,700,000USD5,337,000,000USD5,213,600,000USD5,829,200,000USD4,446,800,000USD
Short Term Debt—7,753,100,000USD—3,290,700,000USD5,276,700,000USD4,587,900,000USD2,333,700,000USD3,332,300,000USD
Short Long Term Debt Total—10,167,800,000USD—8,548,500,000USD6,812,800,000USD6,139,800,000USD4,968,700,000USD4,369,100,000USD
Accumulated Other Comprehensive Income—15,400,000USD—115,200,000USD2,100,000USD-22,600,000USD—-6,000,000USD
Unclassified Current Liabilities—-29,833,700,000USD—-3,290,700,000USD-5,228,000,000USD-4,525,600,000USD-2,333,700,000USD-1,817,400,000USD
Other Current Assets———1,471,700,000USD8,587,100,000USD9,029,700,000USD1,008,600,000USD5,965,200,000USD
Non Current Liabilities Other———7,059,500,000USD——106,000,000USD971,400,000USD
Other Assets—————-21,271,900,000USD——
Current Deferred Revenue—————2,400,000USD—3,700,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Total Assets34,675,100,000USD24,312,500,000USD17,611,600,000USD15,743,900,000USD5,264,600,000USD3,766,821,000USD2,579,985,000USD1,394,911,000USD
Intangible Assets335,400,000USD56,500,000USD56,000,000USD25,600,000USD21,500,000USD14,346,000USD7,830,000USD1,864,000USD
Total Liab33,411,500,000USD23,335,600,000USD16,835,700,000USD15,066,200,000USD4,786,900,000USD3,323,033,000USD2,162,230,000USD1,012,977,000USD
Total Stockholder Equity1,263,800,000USD976,900,000USD775,900,000USD677,700,000USD477,700,000USD443,788,000USD417,755,000USD381,934,000USD
Other Current Liab10,241,600,000USD9,396,100,000USD6,510,500,000USD2,679,600,000USD200,300,000USD122,373,000USD84,160,000USD—
Common Stock100,000USD100,000USD100,000USD100,000USD100,000USD23,000USD23,000USD21,000USD
Capital Stock100,000USD100,000USD100,000USD100,000USD100,000USD———
Retained Earnings982,000,000USD722,400,000USD555,300,000USD455,300,000USD346,600,000USD132,641,000USD107,013,000USD72,279,000USD
Good Will237,400,000USD176,500,000USD163,600,000USD155,500,000USD208,900,000USD198,401,000USD179,175,000USD140,969,000USD
Cash6,378,000,000USD2,556,600,000USD1,483,500,000USD910,100,000USD712,000,000USD291,546,000USD217,501,000USD160,728,000USD
Cash And Short Term Investments13,456,600,000USD5,213,600,000USD4,733,000,000USD3,221,200,000USD758,300,000USD291,546,000USD217,501,000USD—
Total Current Assets24,527,600,000USD23,828,500,000USD16,936,000,000USD15,354,200,000USD4,124,800,000USD291,546,000USD217,501,000USD—
Total Current Liabilities7,753,100,000USD21,779,200,000USD15,884,700,000USD14,561,900,000USD4,630,100,000USD122,373,000USD84,160,000USD—
Net Debt3,789,800,000USD3,583,200,000USD3,904,300,000USD4,818,900,000USD578,100,000USD-44,790,000USD-204,555,000USD-160,728,000USD
Short Term Debt7,753,100,000USD4,587,900,000USD4,440,500,000USD5,224,800,000USD1,136,500,000USD———
Short Long Term Debt7,810,400,000USD4,577,400,000USD3,118,900,000USD4,394,300,000USD140,400,000USD———
Short Long Term Debt Total10,167,800,000USD6,139,800,000USD5,387,800,000USD5,729,000,000USD1,290,100,000USD246,756,000USD12,946,000USD—
Long Term Debt2,327,300,000USD1,484,900,000USD907,900,000USD135,800,000USD136,600,000USD———
Long Term Investments111,600,000USD77,500,000USD77,000,000USD22,000,000USD84,800,000USD———
Short Term Investments7,078,600,000USD2,657,000,000USD3,249,500,000USD2,311,100,000USD46,300,000USD———
Net Receivables11,071,000,000USD9,549,400,000USD7,710,100,000USD9,036,700,000USD2,173,400,000USD———
Inventory483,700,000USD35,800,000USD163,400,000USD35,800,000USD80,100,000USD———
Accounts Payable11,781,700,000USD7,741,000,000USD4,915,200,000USD6,647,600,000USD3,291,200,000USD———
Property Plant Equipment Net110,900,000USD80,700,000USD57,200,000USD45,500,000USD20,900,000USD20,394,000USD27,709,000USD2,481,000USD
Property Plant Equipment Gross160,900,000USD126,800,000USD96,000,000USD78,800,000USD51,400,000USD———
Accumulated Other Comprehensive Income15,400,000USD-22,600,000USD-1,600,000USD-1,700,000USD-3,300,000USD176,797,000USD176,392,000USD175,118,000USD
Common Stock Shares Outstanding76,126,884shares75,279,454shares72,221,843shares70,818,084shares70,818,084shares60,630,837shares60,630,837shares60,630,837shares
Non Current Assets Total10,147,500,000USD484,000,000USD675,600,000USD389,700,000USD1,139,800,000USD3,475,275,000USD2,362,484,000USD1,394,911,000USD
Non Current Liabilities Total25,658,400,000USD1,556,400,000USD951,000,000USD504,300,000USD156,800,000USD3,200,660,000USD2,078,070,000USD1,012,977,000USD
Non Currrent Assets Other3,781,700,000USD46,100,000USD300,400,000USD133,500,000USD799,700,000USD3,242,134,000USD2,147,770,000USD1,249,597,000USD
Net Working Capital2,733,500,000USD2,049,300,000USD1,051,300,000USD792,300,000USD-505,300,000USD———
Unclassified Current Assets-483,700,000USD———————
Unclassified Non Current Assets5,570,500,000USD46,700,000USD21,400,000USD7,600,000USD————
Unclassified Current Liabilities-29,833,700,000USD-4,525,600,000USD-3,100,900,000USD-4,385,400,000USD-138,300,000USD———
Unclassified Non Current Liabilities23,331,100,000USD71,500,000USD-864,800,000USD32,200,000USD-116,400,000USD3,200,660,000USD2,078,070,000USD1,012,977,000USD
Unclassified Equity266,200,000USD276,900,000USD222,000,000USD223,900,000USD134,200,000USD134,327,000USD134,327,000USD134,516,000USD
Other Current Assets—9,029,700,000USD4,329,500,000USD3,060,500,000USD1,113,000,000USD———
Other Assets—-21,271,900,000USD——————
Current Deferred Revenue—2,400,000USD500,000USD1,000,000USD————
Non Current Liabilities Other——907,900,000USD336,300,000USD136,600,000USD———
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Net Income112,400,000USD158,200,000USD73,200,000USD149,200,000USD72,500,000USD115,100,000USD58,400,000USD102,900,000USD
Capital Expenditures0USD-4,300,000USD0USD-8,800,000USD0USD-6,400,000USD0USD-9,200,000USD
Begin Period Cash Flow12,797,600,000USD3,375,300,000USD3,375,300,000USD5,469,500,000USD5,469,500,000USD4,603,900,000USD4,603,900,000USD4,165,900,000USD
Depreciation—19,600,000USD—16,500,000USD———15,400,000USD
Stock Based Compensation—-16,500,000USD—16,500,000USD—-9,700,000USD——
Other Non Cash Items—-2,630,400,000USD—2,583,200,000USD—-130,900,000USD—30,300,000USD
Change To Account Receivables—657,300,000USD—-3,227,500,000USD—-3,138,300,000USD—380,400,000USD
Change To Inventory—-223,200,000USD—-198,800,000USD—87,200,000USD—40,400,000USD
Change In Working Capital—2,208,900,000USD—-1,837,700,000USD—736,500,000USD—303,900,000USD
Total Cash From Operating Activities—-260,200,000USD—927,700,000USD—711,000,000USD—452,500,000USD
Free Cash Flow—-264,500,000USD—918,900,000USD—704,600,000USD—443,300,000USD
Total Cashflows From Investing Activities—-196,200,000USD—-68,100,000USD—-24,600,000USD—-10,700,000USD
Total Cash From Financing Activities—-43,500,000USD—-80,400,000USD—-33,400,000USD—-3,800,000USD
Dividends Paid—-28,200,000USD—-27,300,000USD—-26,400,000USD—-50,700,000USD
Sale Purchase Of Stock—200,000USD—-44,300,000USD———-19,800,000USD
Change In Cash—9,422,300,000USD—-5,469,500,000USD—865,600,000USD—438,000,000USD
End Period Cash Flow—12,797,600,000USD3,375,300,000USD3,375,300,000USD5,469,500,000USD5,469,500,000USD1,914,200,000USD4,603,900,000USD
Other Cashflows From Investing Activities—2,600,000USD—-2,600,000USD—700,000USD——
Other Cashflows From Financing Activities—-18,000,000USD———-7,000,000USD—-1,600,000USD
Unclassified Investing Cash Flow—-194,500,000USD—-56,700,000USD—-18,900,000USD—-1,500,000USD
Unclassified Financing Cash Flow—2,500,000USD—-8,800,000USD———68,300,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Net Income307,400,000USD295,800,000USD141,300,000USD98,200,000USD56,500,000USD43,823,000USD36,392,000USD10,152,000USD
Depreciation36,100,000USD28,800,000USD21,900,000USD13,800,000USD10,300,000USD8,521,000USD7,634,000USD1,417,000USD
Stock Based Compensation43,500,000USD29,600,000USD20,300,000USD16,700,000USD1,200,000USD———
Other Non Cash Items-47,200,000USD-231,100,000USD-57,500,000USD118,900,000USD219,300,000USD518,549,000USD-367,690,000USD293,553,999USD
Change To Account Receivables-2,570,200,000USD-2,757,900,000USD777,600,000USD3,141,100,000USD-1,569,000,000USD-365,081,000USD11,625,000USD-214,284,000USD
Change To Inventory-422,000,000USD127,600,000USD-127,600,000USD44,300,000USD-71,400,000USD-8,774,000USD——
Change In Working Capital371,200,000USD1,040,400,000USD609,000,000USD-22,000,000USD183,500,000USD-616,672,000USD300,525,000USD-174,828,000USD
Total Cash From Operating Activities667,500,000USD1,163,500,000USD735,000,000USD225,600,000USD470,800,000USD-45,779,000USD-23,139,000USD130,294,999USD
Capital Expenditures-13,100,000USD-19,900,000USD-12,100,000USD-9,400,000USD-7,300,000USD-3,363,000USD-2,759,000USD-1,028,999USD
Free Cash Flow654,400,000USD1,143,600,000USD722,900,000USD216,200,000USD463,500,000USD-49,142,000USD-25,898,000USD129,265,999USD
Investments-2,900,000USD-35,300,000USD-97,600,000USD-46,300,000USD-19,800,000USD———
Total Cashflows From Investing Activities-264,300,000USD-35,300,000USD-97,600,000USD-46,300,000USD-19,800,000USD-31,052,000USD-106,154,000USD-2,594,000USD
Net Borrowings-24,300,000USD-8,600,000USD-11,400,000USD-56,600,000USD-7,200,000USD———
Total Cash From Financing Activities-123,900,000USD-37,200,000USD-72,800,000USD26,500,000USD-27,200,000USD150,876,000USD186,066,000USD-56,197,000USD
Dividends Paid-55,500,000USD-77,100,000USD-58,300,000USD-6,600,000USD-20,000,000USD-18,195,000USD——
Sale Purchase Of Stock-44,100,000USD-19,800,000USD-3,100,000USD-7,900,000USD0USD———
Issuance Of Capital Stock0USD73,100,000USD0USD0USD————
Change In Cash7,328,100,000USD1,073,100,000USD573,400,000USD198,100,000USD420,500,000USD74,045,000USD56,773,000USD71,504,000USD
Begin Period Cash Flow5,469,500,000USD1,483,500,000USD910,100,000USD1,328,500,000USD291,500,000USD217,501,000USD160,728,000USD89,224,000USD
End Period Cash Flow12,797,600,000USD2,556,600,000USD1,483,500,000USD3,248,700,000USD1,328,500,000USD291,546,000USD217,501,000USD160,728,000USD
Other Cashflows From Financing Activities-18,000,000USD-4,800,000USD-97,600,000USD-2,400,000USD-19,800,000USD-6,198,000USD186,066,000USD-56,197,000USD
Unclassified Operating Cash Flow-43,500,000USD———————
Unclassified Investing Cash Flow-248,300,000USD28,100,000USD16,800,000USD15,200,000USD10,800,000USD-18,718,000USD-110,150,000USD—
Unclassified Financing Cash Flow18,000,000USD73,100,000USD97,600,000USD100,000,000USD19,800,000USD175,269,000USD——
Other Cashflows From Investing Activities—-8,200,000USD-4,700,000USD-5,800,000USD-3,500,000USD-8,971,000USD6,755,000USD-1,565,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Operating metrics

No operating metrics are currently published for this company.

Revenue breakdown

PeriodDimensionBusiness / regionRevenueCurrencySource
Q3 2012Quarterly · 2012-09-30SegmentAcne And Acne Related Dermatological Products85,109,000USD0001193125-12-461078
Q3 2012Quarterly · 2012-09-30SegmentNon Acne Dermatological Products80,773,000USD0001193125-12-461078
Q3 2012Quarterly · 2012-09-30SegmentNon Dermatological Products14,313,000USD0001193125-12-461078
Q2 2012Quarterly · 2012-06-30SegmentAcne And Acne Related Dermatological Products93,131,000USD0001193125-12-344559
Q2 2012Quarterly · 2012-06-30SegmentNon Acne Dermatological Products81,113,000USD0001193125-12-344559
Q2 2012Quarterly · 2012-06-30SegmentNon Dermatological Products22,310,000USD0001193125-12-344559
Q1 2012Quarterly · 2012-03-31SegmentAcne And Acne Related Dermatological Products108,501,000USD0001193125-12-218847
Q1 2012Quarterly · 2012-03-31SegmentNon Acne Dermatological Products73,998,000USD0001193125-12-218847
Q1 2012Quarterly · 2012-03-31SegmentNon Dermatological Products19,244,000USD0001193125-12-218847
Q4 2011Quarterly · 2011-12-31SegmentAcne And Acne Related Dermatological Products101,874,000USDLegacy provider
Q4 2011Quarterly · 2011-12-31SegmentNon Acne Dermatological Products64,004,000USDLegacy provider
Q4 2011Quarterly · 2011-12-31SegmentNon Dermatological Products14,840,000USDLegacy provider
FY 2011Yearly · 2011-12-31SegmentAcne And Acne Related Dermatological Products447,585,000USD0001193125-12-082132
FY 2011Yearly · 2011-12-31SegmentNon Acne Dermatological Products229,603,000USD0001193125-12-082132
FY 2011Yearly · 2011-12-31SegmentNon Dermatological Products43,938,000USD0001193125-12-082132
Q3 2011Quarterly · 2011-09-30SegmentAcne And Acne Related Dermatological Products119,119,000USD0001193125-12-461078
Q3 2011Quarterly · 2011-09-30SegmentNon Acne Dermatological Products55,659,000USD0001193125-12-461078
Q3 2011Quarterly · 2011-09-30SegmentNon Dermatological Products9,890,000USD0001193125-12-461078
Q2 2011Quarterly · 2011-06-30SegmentAcne And Acne Related Dermatological Products123,130,000USD0001193125-12-344559
Q2 2011Quarterly · 2011-06-30SegmentNon Acne Dermatological Products57,719,000USD0001193125-12-344559
Q2 2011Quarterly · 2011-06-30SegmentNon Dermatological Products9,978,000USD0001193125-12-344559
Q1 2011Quarterly · 2011-03-31SegmentAcne And Acne Related Dermatological Products103,462,000USD0001193125-12-218847
Q1 2011Quarterly · 2011-03-31SegmentNon Acne Dermatological Products52,221,000USD0001193125-12-218847
Q1 2011Quarterly · 2011-03-31SegmentNon Dermatological Products9,230,000USD0001193125-12-218847
FY 2010Yearly · 2010-12-31SegmentAcne And Acne Related Dermatological Products482,359,000USD0001193125-12-082132
FY 2010Yearly · 2010-12-31SegmentNon Acne Dermatological Products174,978,000USD0001193125-12-082132
FY 2010Yearly · 2010-12-31SegmentNon Dermatological Products38,595,000USD0001193125-12-082132
Q3 2010Quarterly · 2010-09-30SegmentAcne And Acne Related Dermatological Products118,506,000USD0001193125-11-304486
Q3 2010Quarterly · 2010-09-30SegmentNon Acne Dermatological Products49,499,000USD0001193125-11-304486
Q3 2010Quarterly · 2010-09-30SegmentNon Dermatological Products9,091,000USD0001193125-11-304486
FY 2009Yearly · 2009-12-31SegmentAcne And Acne Related Dermatological Products398,861,000USD0001193125-12-082132
FY 2009Yearly · 2009-12-31SegmentNon Acne Dermatological Products133,595,000USD0001193125-12-082132
FY 2009Yearly · 2009-12-31SegmentNon Dermatological Products38,191,000USD0001193125-12-082132

Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.